Composite wound dressing
    23.
    发明公开
    Composite wound dressing 失效
    复合绕线

    公开(公告)号:EP0227955A3

    公开(公告)日:1987-11-25

    申请号:EP86116467

    申请日:1983-07-20

    发明人: Juhasz, Laszlo

    IPC分类号: A61L15/01 A61F13/00

    摘要: The multilayered composite wound dressing comprises of a semipermeable membrane (10), optionally with a permeable supporting and reinforcing layer, and a non-­stick, self-sealing biodegradable tissue interface (11). The semipermeable membrane may be a synthetic collagen, an alginate or a biocompatible polymer and it controls the rate of water vapour transmission from the wound surface. The permeable supporting and reinforcing layer provides mechanical strength and is usually a textile fabric. The biodegradable tissue interface may be synthetic collagen, sodium-calcium alginate or collagen-­alginate complex, and it provides non-stick haemostatic sealing and aids the wound repair processes. For topical medication, growth promoting, antibacterial, anti­allergic and therapeutic agents may also be incorporated.

    摘要翻译: 多层复合伤口敷料包括半透膜,透气性支撑和增强层,以及不粘,自密封的可生物降解的组织界面。 半透膜可以是合成胶原,藻酸盐或生物相容性聚合物,并且它控制从伤口表面传递水蒸气的速率。 可渗透的支撑和增强层提供机械强度,并且通常是纺织织物,其也可以通过用掺碳的硅或天然橡胶涂布或在织物上沉积金属而被制成导电的。 或者,也可以使用活性炭布织物。 可生物降解的组织界面可以是合成胶原,藻酸钠钙或胶原 - 藻酸盐复合物,并且它提供不粘的止血密封并辅助伤口修复过程。 对于局部用药,还可以引入生长促进剂,抗细菌剂,抗过敏剂和治疗剂。 适用于特定层的每种材料的任何组合可用于特定应用。 导电支撑和增强层可以用于使用已经显示出增强伤口愈合过程,产生术后疼痛缓解和细菌抑制的外部场的电荷传递和刺激。 复合伤口敷料尤其适用于治疗一般手术伤口,烧伤,褥疮,感染性溃疡,皮肤移植物的供体部位,或者可用于经皮和功能性刺激中的电极敷料。

    Composite wound dressing
    24.
    发明公开
    Composite wound dressing 失效
    Mehrschichtiger Wundferband。

    公开(公告)号:EP0227955A2

    公开(公告)日:1987-07-08

    申请号:EP86116467.1

    申请日:1983-07-20

    发明人: Juhasz, Laszlo

    IPC分类号: A61L15/01 A61F13/00

    摘要: The multilayered composite wound dressing comprises of a semipermeable membrane (10), optionally with a permeable supporting and reinforcing layer, and a non-­stick, self-sealing biodegradable tissue interface (11). The semipermeable membrane may be a synthetic collagen, an alginate or a biocompatible polymer and it controls the rate of water vapour transmission from the wound surface. The permeable supporting and reinforcing layer provides mechanical strength and is usually a textile fabric. The biodegradable tissue interface may be synthetic collagen, sodium-calcium alginate or collagen-­alginate complex, and it provides non-stick haemostatic sealing and aids the wound repair processes. For topical medication, growth promoting, antibacterial, anti­allergic and therapeutic agents may also be incorporated.

    摘要翻译: 所述多层复合伤口敷料包括半透膜(10),任选地具有可渗透的支撑和增强层,以及不粘的,自密封的可生物降解的组织界面(11)。 半透膜可以是合成胶原,藻酸盐或生物相容性聚合物,并且它控制从伤口表面传递水蒸气的速率。 可渗透的支撑和增强层提供机械强度,并且通常是纺织织物。 可生物降解的组织界面可以是合成胶原,藻酸钠钙或胶原 - 藻酸盐复合物,并且它提供不粘的止血密封并辅助伤口修复过程。 对于局部用药,还可以引入生长促进剂,抗细菌剂,抗过敏剂和治疗剂。

    GELLING FIBRES
    25.
    发明公开
    GELLING FIBRES 审中-公开

    公开(公告)号:EP3377682A1

    公开(公告)日:2018-09-26

    申请号:EP15801217.9

    申请日:2015-11-18

    IPC分类号: D01D5/06 D01F2/28 D01F9/04

    摘要: Fibres suitable for use in the production of wound dressings comprise carboxymethyl cellulose and alginate in a total amount of at least 90% by weight of the fibre, the carboxymethyl cellulose and alginate are homogeneously distributed throughout the fibre and are present in amounts such that: (a) the amount of carboxymethyl cellulose present in the fibre is at least 50% by weight of the total weight of the carboxymethyl cellulose and alginate; (b) the alginate has a Guluronate-content of 50-90% by weight, and (c) the value of z given by the expression (1): z=(2x/40)/(2x/40)+(y/23) where x and y are the percentages by weight of calcium and sodium respectively in the fibres is at least 80. The fibres may be produced by spinning a solution comprising dissolved CMC and alginate in appropriate proportions into a coagulation bath containing calcium ions.

    SCHAUMWUNDAUFLAGE FÜR DIE UNTERDRUCKTHERAPIE
    30.
    发明公开
    SCHAUMWUNDAUFLAGE FÜR DIE UNTERDRUCKTHERAPIE 有权
    SCHAUMWUNDAUFLAGEFÜRDIE UNTERDRUCKTHERAPIE

    公开(公告)号:EP3139877A1

    公开(公告)日:2017-03-15

    申请号:EP15720670.7

    申请日:2015-04-28

    申请人: Paul Hartmann AG

    IPC分类号: A61F13/00

    摘要: The present invention relates to a wound dressing for use in vacuum therapy of wounds, comprising a first layer composed of a first porous foam, a second layer composed of a second porous foam, wherein the second layer is connected non-releasably to the first layer, a multiplicity of through-openings which pass like channels all the way through both layers, characterized in that the first foam differs from the second foam in terms of the chemical composition of the foam and/or in terms of a property of the foam including the cell count, measured in cells per inch, the apparent density measured according to DIN EN ISO 84, the compression load deflection measured according to ISO 3386-1, the elongation at break measured according to DIN 5357, wherein the wound dressing, as used in vacuum therapy, can be introduced into the wound with its first layer pointing towards the wound base or with its second layer pointing towards the wound base, depending on the choice made by the user.

    摘要翻译: 本发明涉及一种用于伤口真空治疗的伤口敷料,包括由第一多孔泡沫构成的第一层,由第二多孔泡沫构成的第二层,其中第二层不可释放地连接到第一层 ,多个通孔通过两层通过相似的通道,其特征在于,就泡沫的化学组成和/或泡沫的性质而言,第一泡沫与第二泡沫不同,泡沫的性质包括 根据DIN EN ISO 84测量的细胞计数,以DIN EN ISO 84测量的表观密度,根据ISO 3386-1测量的压缩载荷挠度,根据DIN 5357测量的断裂伸长率,其中使用的伤口敷料 在真空治疗中,可以根据使用者的选择将其第一层指向伤口基部或其第二层指向伤口基底,从而引入伤口中。